Using wearable devices to encourage physical activity in cancer survivors
Personalized Feedback of Wearable Biological Sensor Data to Promote Active Living in Cancer Survivors
This study is testing whether using wearable devices to give cancer survivors real-time feedback on their glucose levels can help them be more active and improve their health.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 50 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | The University of Texas at Arlington Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Arlington, Texas) |
| Trial ID | NCT05490641 on ClinicalTrials.gov |
What this trial studies
This study promotes daily physical activity among cancer survivors at high risk for type 2 diabetes by utilizing a personalized biological feedback strategy. Participants will be randomly assigned to receive either personalized feedback based on real-time glucose monitoring or standard educational materials. The study aims to evaluate the feasibility and preliminary efficacy of this 12-week intervention in increasing physical activity levels and understanding the relationship between daily glucose patterns and cancer-related biomarkers. By leveraging wearable sensor technology, the study seeks to motivate participants to connect their daily behaviors with health outcomes.
Who should consider this trial
Good fit: Ideal candidates include cancer survivors aged 18 and older who have completed curative treatment and are currently insufficiently active.
Not a fit: Patients currently taking oral antidiabetic agents or those with a diagnosis of type 1 or 2 diabetes may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve physical activity levels and health outcomes for cancer survivors at risk for type 2 diabetes.
How similar studies have performed: While the use of wearable devices for health monitoring is gaining traction, this specific approach combining glucose feedback with physical activity in cancer survivors is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * be 18 years or older * have had a diagnosis of cancer * have completed curative-intended treatment for at least 3 months (except hormone therapy or long-term maintenance chemotherapy) * be at high-risk for type 2 diabetes based on the American Diabetes Association Type 2 Diabetes Risk Test * currently insufficiently active * capable of participating in moderate-vigorous intensity unsupervised exercise * have no current diagnosis or history of type 1 or 2 diabetes * able to speak, read, and write in English * have a smartphone with daily internet access Exclusion Criteria: * currently taking oral antidiabetic agents (OADs) * current treatment with any insulin regimen other than basal insulin, e.g. prandial or pre-mixed insulin * currently pregnant * on dialysis * have self-reported health issues that limit physical activity * work overnight shifts * unwilling to use the study devices * current participation in other exercise or weight loss-related program or intervention * currently on a low-carb diet * current use of other implanted medical devices such as pacemakers * do not have a smartphone that is compatible with the Fitbit and the LibreLink apps
Where this trial is running
Arlington, Texas
- The University of Texas at Arlington — Arlington, Texas, United States (Recruiting)
Study contacts
- Principal investigator: Yue Liao, MPH, PhD — University of Texas at Arlington
- Study coordinator: Yue Liao, MPH, PhD
- Email: yue.liao@uta.edu
- Phone: 18172728529
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.